Skip Navigation

Cardiovascular Research 1999 43(4):884-891; doi:10.1016/S0008-6363(99)00123-6
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Purcell, I. F
Right arrow Articles by Marston, S. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Purcell, I. F
Right arrow Articles by Marston, S. B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts

Ian F Purcell*, Wu Bing and Steven B Marston

Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK

* Corresponding author. Tel.: +44-171-3528121; fax: +44-171-8233392 i.purcell{at}ic.ac.uk

Objective: Human cardiac development and heart failure are associated with altered troponin isoform expression and phosphorylation. As the functional effects of these changes in troponin are unknown, we isolated troponin from human foetal, normal adult and failing adult hearts and investigated their regulatory function. Methods: Human cardiac troponin was assayed for regulatory function by in vitro motility assay and for protein content by SDS PAGE and immunoblotting. Results: Human cardiac troponin regulated movement of actin–tropomyosin filaments over a bed of immobilised heavy meromyosin. At pCa 9, troponin from foetal and adult hearts reduced the fraction of filaments moving from 90% to less than 15% with a modest (25–30%) decrease in velocity. At pCa 5, troponin from normal adult hearts increased filament velocity by up to 47±3% with no change in the fraction of filaments moving. Foetal troponin increased velocity by only 4±6% and the effect of troponin from failing hearts was between these values at 31±5%. Foetal hearts showed different troponin I and T isoform expression compared with adult hearts. No differences in troponin isoform expression were demonstrated between normal and failing adult hearts. Conclusions: Functioning troponin and tropomyosin may be isolated from human heart and their properties investigated by in vitro motility assay. Both functional and isoform expression differences exist between foetal and adult cardiac troponin. The regulatory function of troponin from adults with end stage heart failure is different from normal adult troponin. These data suggest a role for altered troponin function in human cardiac development and heart failure.

KEYWORDS Contractile apparatus; Contractile function; Heart failure; Developmental biology; Cardiomyopathy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Heart FailHome page
E. C. Dyer, A. M. Jacques, A. C. Hoskins, D. G. Ward, C. E. Gallon, A. E. Messer, J. P. Kaski, M. Burch, J. C. Kentish, and S. B. Marston
Functional Analysis of a Unique Troponin C Mutation, GLY159ASP, that Causes Familial Dilated Cardiomyopathy, Studied in Explanted Heart Muscle
Circ Heart Fail, September 1, 2009; 2(5): 456 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mirza, S. Marston, R. Willott, C. Ashley, J. Mogensen, W. McKenna, P. Robinson, C. Redwood, and H. Watkins
Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype
J. Biol. Chem., August 5, 2005; 280(31): 28498 - 28506.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. B. Marston and C. S. Redwood
Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications
Circ. Res., December 12, 2003; 93(12): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Robinson, M. Mirza, A. Knott, H. Abdulrazzak, R. Willott, S. Marston, H. Watkins, and C. Redwood
Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy
J. Biol. Chem., October 18, 2002; 277(43): 40710 - 40716.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
J. H. Marden, G. H. Fitzhugh, M. Girgenrath, M. R. Wolf, and S. Girgenrath
Alternative splicing, muscle contraction and intraspecific variation: associations between troponin T transcripts, Ca2+ sensitivity and the force and power output of dragonfly flight muscles during oscillatory contraction
J. Exp. Biol., March 12, 2002; 204(20): 3457 - 3470.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Redwood, K. Lohmann, W. Bing, G. M. Esposito, K. Elliott, H. Abdulrazzak, A. Knott, I. Purcell, S. Marston, and H. Watkins
Investigation of a Truncated Cardiac Troponin T That Causes Familial Hypertrophic Cardiomyopathy : Ca2+ Regulatory Properties of Reconstituted Thin Filaments Depend on the Ratio of Mutant to Wild-Type Protein
Circ. Res., June 9, 2000; 86(11): 1146 - 1152.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.